ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 740 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 740; 2) Community: the network communities that were significantly associated with the response to NSC 740; 3) Molecule: the relationships between components within communities and NSC 740; 4) MDR: the compounds that were significantly associated with the NSC 740.

NSC Compound Enrichment Correlation
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0342636096654271 0.83125777
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0342636096654271 0.73043286
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0342636096654271 0.51589783
NSC 374998 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyrimidinyl)ethylidene] hydrazide 0.0342636096654271 0.49501153
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0342636096654271 0.48118927
NSC 48229 Null 0.0342636096654271 -0.24689633
NSC 602313 Null 0.0342636096654271 0.7730844
NSC 610456 Camptothecin Derivative 0.0342636096654271 0.65154644
NSC 614495 B723735K022 0.0342636096654271 0.34257118
NSC 625736 Null 0.0342636096654271 0.013110266
Total:122  Current:82    [First] [Prev] [Next] [Last]